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Background: The first night effect (FNE) is a polysomnography (PSG) habituation effect 
in the first of several consecutive in-laboratory PSGs (I-PSGs). The FNE is caused by the 
discomfort provoked by electrodes and cables and the exposure to an unfamiliar environment. 
A reverse FNE (RFNE) with an improved sleep in the first night is characteristic of insomnia, 
presumably because the video PSG in the sleep laboratory leads to a decrease in the negatively 
toned cognitive activity. Therefore, two or more I-PSGs are required for an accurate diagnosis. 
Although the FNE is well documented in I-PSG, little is known about the FNE and the RFNE 
in home-based PSGs (H-PSGs).
Methods: This is a retrospective analysis of a recently published cross-sectional study using 
H-PSG. Sixty-three consecutive patients suffering from multiple sclerosis (MS) were investi-
gated by two consecutive H-PSGs without video. The differences between the first and second 
H-PSGs were analyzed. The patients were classified into four subgroups: no sleep disorder, 
insomnia, sleep-related breathing disorders (SRBDs), and periodic limb movement disorder or 
restless legs syndrome (PLMD/RLS).
Results: MS patients suffering from insomnia showed no RFNE. MS patients with SRBD or 
PLMD/RLS showed no reduced sleep efficiency but significantly less slow wave sleep. Fur-
thermore, SRBD patients showed significantly less non-rapid eye movement (NREM) sleep, 
and PLMD/RLS patients were significantly awake longer in the first night after sleep onset 
(increased wake-after-sleep-onset time) and showed a higher rapid eye movement (REM) latency.
Conclusion: SRBD and PLMD/RLS patients showed a significant FNE. Two consecutive 
H-PSGs are required in these patients to obtain a precise hypnogram even in the ambulatory 
field. In MS patients suffering from insomnia, no RFNE was found, and in insomnia patients 
one H-PSG seems to be sufficient.
Keywords: insomnia, multiple sclerosis, outpatient sleep studies, polysomnography, sleep 
latency, wake after sleep onset
Introduction
Polysomnography (PSG) is the gold standard for diagnosing many different sleep 
disorders, in particular, obstructive sleep apnea syndrome (OSAS) and is restricted 
for the diagnosis of only the most severe sleep disorders due to its low availability and 
high cost.1,2 Polygraphy (PG) is often used as an alternative diagnostic technique for 
diagnosing OSAS,3 but it is insufficient to rule out OSAS.4 Actigraphy is often used to 
estimate sleep–wake time and to measure body position.5–7 To reduce the numbers of 
PSG and save resources, new technologies such as automated electroencephalography-
based single-channel sleep–wake detection algorithms or actigraphy combined with 
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respiratory effort have been described, which are not yet part 
of routine clinical practice, and up to date PSG remains the 
gold standard.8,9
In one recently published study, 187 adults suffering from 
sleepiness or tiredness who had undergone previously ambu-
lant PG and were considered to be normal were afterward 
investigated by PSG: the authors found at least mild OSAS 
in 90%, and 64% showed even moderate-to-severe OSAS.4 
Even if the authors concluded that PG is insufficient to rule 
out OSAS when the respiratory events are mainly associated 
with arousals, due to the increasing demand for in-laboratory 
PSG (I-PSG) and long waiting lists of the most sleep centers, 
PG is nevertheless increasingly utilized in this issue.10 The 
advantage of self-administrated home-based PSG (H-PSG) 
recordings is that they are less time-consuming and less 
cost-intensive. Bruyneel and Ninane11 reviewed recently six 
prospective randomized crossover studies comparing H-PSG 
to I-PSG. These six studies showed that unattended H-PSG 
shows a low failure rate despite the absence of supervision, 
and it is sufficiently accurate for OSAS diagnosis. Moreover, 
the quality of patients’ sleep tends to be better at home.11 
PSGs were usually performed in the sleep laboratory (I-PSG). 
Several I-PSG studies in healthy volunteers (HVs) and 
insomniacs showed, on the first PSG recording, a lower total 
sleep time (TST) and reduced rapid eye movement (REM) 
sleep with increased sleep onset latencies (SOLs) and REM 
sleep latencies (RSLs), lower sleep efficacy (SE), and higher 
wake-time-after-sleep-onset (WASO) time as compared to 
the second PSG, whereas the total amount of non-REM 
(NREM) sleep remains unchanged.12,13 This so-called first 
night effect (FNE) is caused by the discomfort provoked 
by electrodes and cables and the exposure to an unfamiliar 
environment.12,14 It is not known whether and to what extent 
there is an FNE in H-PSG.
It has generally been considered that H-PSG in contrast 
to I-PSG does not provoke an FNE because the change in 
environment has a larger impact than the H-PSG itself.14 
Repeated studies on overall 100 persons failed to demonstrate 
an FNE in HVs and insomniacs at home.15–17 However, two 
studies showed FNE in the home environment as well, com-
parable to recordings in the sleep laboratory – although to 
a lesser extent: Le Bon et al14 investigated 26 HVs at home, 
and they found a classic FNE between night 1 and night 2 
regarding SE, WASO time, awakenings (AWAs), and REM 
sleep, whereas the duration of NREM sleep remained the 
same. Wauquier et al18 found an FNE in two consecutive 
24-hour ambulatory PSG home sleep–wake recordings of 
10 elderly persons with a mean age of 86 years.
Moreover, Blackwell et al19 used actigraphy to quantify 
the sleep disruption level caused by H-PSG. They inves-
tigated 778 male subjects aged 65 years and older from a 
population-based study by H-PSG, and the simultaneous 
actigraphy was performed on the PSG night and three 
subsequent nights.19 Sleep on the first H-PSG night was 
significantly worse than in the following nights (less acti-
graphically measured TST and SE, more WASO and SOL). 
Among others, older age was associated with greater sleep 
disruption on the PSG night.
In 2011, we published the results of the first PSG cross-
sectional trial in multiple sclerosis (MS) patients, which we 
performed over two consecutive nights at home.20 The aim 
of the present retrospective data analysis was to evaluate a 
possible FNE in our original cohort. Moreover, we analyzed 
the so-called “reversed” or “paradoxical” FNE (RFNE).21 The 
RFNE is characterized in insomniacs by the observation of 
decreased SOL, decreased REM latency, a higher percent-
age of REM, and greater SE in the first night compared to 
the second night.
Patients and methods
Participants and procedures
In this study, we investigated 66 consecutive MS patients by 
two H-PSGs using the Rechtschaffen and Kales (R&K) crite-
ria for classification of sleep stages, the Coleman criteria for 
classifying periodic leg movement (PLM), and the diagnostic 
guidelines of the Task Force of the American Academy of 
Sleep Medicine (AASM) for respiratory events.20,22–25 In the 
present analysis, 63 patients were included (due to missing 
data in three patients of the first night). We retrospectively 
analyzed the PSG data from the two consecutive nights (PLM 
index [PLMI] per hour sleep, PLM arousal index [PLM-AI] 
per hour sleep), SE (percentage of TST per time spent in bed 
[TiB]), percentage of slow wave sleep (NREM 3 and 4) per 
TiB, percentage of NREM 1 and 2 sleep per TiB, percent-
age of REM sleep per TiB, percentage of NREM sleep per 
TiB, SOL in minutes, WASO in minutes, number of AWAs, 
and arousal indexes (AIs). This study was approved by the 
local ethics committees (institutional review board of the 
University of Greifswald, Germany; vote number BB 03/08), 
and all the participants gave written informed consent prior 
to the assessment.
Statistical analyses
The results are reported as frequencies and percentages 
for categorical variables and mean and standard deviation 
(SD) for sufficiently normally distributed continuous data 
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(|skewness|<1) or median and limits of the inter-quartile 
range (IQR) for quantitatively skewed variables. Changes (∆) 
in sleep parameters were calculated in different subgroups 
as the difference between the second and first night and 
compared using Wilcoxon signed-rank test (Tables 1 and 2) 
within each sleep disorder subgroup. Differences in sleep 
parameter changes between the four subgroups were tested 
using Kruskal–Wallis test. All tests were two sided with 
a significant level of 0.05. To detect associations between 
changes in sleep parameters and patients’ age, we used 
Spearman’s rank correlations for univariate analyses within 
each subgroup. A correlation coefficient close to zero means 
that the change between the two nights does not or only very 
weakly correlate with age. The larger the correlation coeffi-
cient (maximum possible absolute value is |1|), the greater the 
impact of age on the changes in H-PSG parameters. Scatter 
plots are given to illustrate correlations. We rated Spearman’s 
rank correlations (Spearman’s rho) as follows: for values 
equal or greater than 0.4, the correlation is at least moderate 
or stronger; for values lower than 0.4, the correlation is weak 
and considered not of relevance. No further adjustment for 
multiple comparisons has been applied. All tests should be 
understood as constituting exploratory data analysis.
Results
Baseline characteristics and demographic data are given 
in Table 1. Due to the RFNE in insomniacs, the FNE was 
not calculated in the entire cohort but calculated separately 
Table 1 Baseline characteristics
Insomnia  
(n=17)
No sleep disorder 
(n=17)
SRBD  
(n=7)
PLMD/RLS 
(n=22)
Total  
(N=63)
Sex Female, N (%) 13 (76.5) 14 (82.4) 5 (71.4) 11 (50.0) 43 (68.3)
Age (years) Mean (SD) 46 (10) 36 (9) 51 (10) 44 (9) 43 (10)
Time since onset (years) Median (iQr) 9 (7–22) 5 (4–11) 10 (3–24) 11 (4–18) 9 (4–18)
Expanded Disability Status Scale Median (iQr) 2 (2–3) 2 (2) 4 (3–6) 2 (2–4) 2 (2–4)
Beck Depression Inventory Median (iQr) 15 (12–23) 5 (2–8) 14 (11–33) 9 (6–16) 10 (6–18)
Modified Fatigue Impact Scale Median (iQr) 48 (44–54) 20 (2–31) 57 (45–64) 33 (19–48) 38 (20–52)
Fatigue Severity Scale Median (iQr) 5.7 (5.1–6.5) 3.1 (1.4–4.4) 6.3 (5.7–6.9) 4.0 (2.9–5.4) 4.7 (3.1–6.3)
Disease-modifying therapy Missings n 1 1 0 4 6
copaxone n (%) 3 (18.8) 9 (56.3) 3 (42.9) 5 (27.8) 20 (35.1)
cortisone plus n (%) 0 1 (6.3) 0 0 1 (1.8)
interferon n (%) 7 (43.8) 5 (31.3) 3 (42.9) 7 (38.9) 22 (38.6)
iVig n (%) 0 1 (6.3) 0 1 (5.6) 2 (3.5)
No therapy n (%) 3 (18.8) 0 1 (14.3) 5 (27.8) 9 (15.8)
Mitoxantrone n (%) 2 (12.5) 0 0 0 2 (3.5)
Natalizumab n (%) 1 (6.3) 0 0 0 1
antidepressants Yes n (%) 5 (29.4) 5 (29.4) 0 4 (18.2) 14 (22.2)
Psychopharmaka Yes n (%) 5 (29.4) 1 (5.9) 2 (28.6) 8 (36.4) 16 (25.4)
Abbreviations: IVIG, polyvalent intravenous globulin; PLMD, periodic limb movement disorder; RLS, restless legs syndrome; SRBD, sleep-related breathing disorder.
in the four sleep disorder subgroups. The results are sum-
marized in Table 2. Apart from an increased number of 
AWAs in the first night, MS patients without sleep disorders 
showed no significant differences between the two nights. 
MS patients suffering from sleep-related breathing disorders 
(SRBDs, six OSAS patients and one patient suffering from 
central sleep apnea) showed significantly less NREM sleep 
and slow wave sleep in the first night (12.5% and 2.8%, 
respectively) compared to the second night (55.2% and 
8.3%, respectively; P=0.043 and P=0.028, respectively). 
Moreover, SRBD patients showed 30 minutes more WASO 
in the first night compared to the second night (P=0.176). 
Periodic limb movement disorder or restless legs syndrome 
(PLMD/RLS) patients showed less slow wave sleep in the 
first night (7.2% vs 9.3%; P=0.008) and, furthermore, sig-
nificantly more WASO (80 vs 69 minutes; P=0.029) and 
a higher REM latency (79 vs 61 minutes; P=0.027) in the 
first night compared to the second night. Insomniacs showed 
changes between the two consecutive nights, consistent with 
the described RFNE in the literature although they failed to 
reach statistical significance in our data set: shorter SOL (41 
vs 54 minutes; P=0.705) in the first night and a higher SE 
(72.7% vs 70.2%; P=0.407).
Table 3 summarizes the Spearman’s rank correlations 
between changes in sleep parameters between night 1 and 
night 2 (Delta = Δ) and age. Only a few moderate correla-
tions were found. In MS patients without sleep disorders, 
the change in AI was significantly correlated with age 
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(rho =0.517): older patients showed a larger decrease in AI 
between the first and second night than younger MS patients 
without sleep disorders (as a sign of a slight FNE in older 
patients). In addition, in MS patients suffering from insomnia, 
the change in REM latency was significantly correlated with 
age (rho =−0.620): older patients showed a smaller increase 
up to a decrease in REM latency. In PLMD/RLS patients, the 
changes in SOL and REM sleep were significantly correlated 
with age too (rho =–0.424 and rho =0.451, respectively). 
In MS patients suffering from SRBD, there were moderate 
correlations with age and changes in the number of AWAs 
(rho =−0.477), NREM sleep (rho =0.468), NREM sleep 1+2 
(rho =0.577), and SOL (rho =−0.450). Figure 1 illustrates the 
Table 2 Hypnogram parameters: night 1 and median change to night 2 (∆: night 2–night 1)
Insomnia (n=17) No sleep  
disorder (n=17)
SRBD (n=7) PLMD/RLS  
(n=22)
AI per hour sleep (first night)
∆ second night vs first night
21.0 (14.7–29.3)  
–1 (–6 to 3)
P=0.737
18.9 (13.1–27.0)
–1 (–3 to 2)
P=0.959
23.6 (11.0–40.6)
–3 (–3 to 6)
P=0.735
15.9 (12.3–46.0)
0 (–3 to 1)
P=0.052
WASO in minutes (first night)
∆ second night vs first night
83 (57–136)
–7 (–21 to 36)
P=0.962
68 (53–85)
–12 (–30 to 0)
P=0.112
174 (74–218)
–30 (–85 to 3)
P=0.176
80 (55–109)
–11 (–31 to 0)
P=0.029
Number of sleep stage changes (first night)
∆ second night vs first night
157 (116–188)
–21 (–26 to 26)
P=0.636
163 (138–206)
–7 (–51 to 2)
P=0.115
153 (109–218)
10 (–24 to 22)
P=0.799
146 (123–178)
2 (–36 to 24)
P=0.970
Numbers of AWAs (first night)
∆ second night vs first night
25 (22–35)
0 (–5–7)
P=0.532
27(17–39)
–5 (–9 to 2)
P=0.041
34 (27–48)
2 (0 to 7)
P=0.498
27 (17–32)
0 (–9 to 5)
P=0.808
SE in percent of TSiB (first night)
∆ second night vs first night
72.7 (65.2–81.4)
–2.5 (–10.2 to 6.2)
P=0.407
82.9 (78.2–86.9)
1.8 (–1.8 to 4.2)
P=0.313
66.4 (59.4–84.4)
4.2 (–7.8 to 19.0)
P=0.310
76.5 (69.9–83.4)
–0.1 (–3.5 to 5.8)
P=0.986
N1 and N2 in percent of TB (first night)
∆ second night vs first night
50.8 (43.8–60.9)
–3.6 (–12.8 to 3.6)
P=0.256
52.3 (46.7–62.1)
0 (–7.0 to 7.8)
P=0.959
47.4 (36.2–51.7)
11.0 (–6.2 to 12.4)
P=0.398
52.5 (47.1–64.1)
0 (–6.5 to 5.1)
P=0.502
REM sleep in percent of TB (first night)
∆ second night vs first night
12.2 (8.2–16.0)
0.7 (–1.9 to 4.7)
P=0.670
13.5 (10.0–18.0)
0.5 (–3.6 to 6.4)
P=0.443
13.1 (6.8–18.3)
–0.1 (–4.3 to 6.2)
P=0.735
14.3 (7.7–15.8)
0.8 (–2.7 to 5.3)
P=0.390
SWS in percent of TB (first night)
∆ second night vs first night
7.4 (3.7–12.0)
2.2 (–1.1 to 7.0)
P=0.079
11.4 (7.6–16.5)
4.0 (–0.6 to 6.4)
P=0.070
8.3 (5.8–10.7)
2.8 (1.4–14.1)
P=0.028
7.2 (3.8–12.0)
2.1 (0.5–6.7)
P=0.008
NREM sleep in percent of TB (first night)
∆ second night vs first night
61.6 (53.0–70.3)
1.3 (–5.4 to 10.3)
P=0.943
65.9 (61.1–69.4)
4.0 (–3.6 to 6.9)
P=0.177
55.2 (45.9–65.0)
12.5 (4.6 to 14.1)
P=0.043
62.7 (58.6–67.2)
5.2 (–5.1 to 7.9)
P=0.263
REM latency in minutes (first night)
∆ second night vs first night
75 (58–104)
–5 (–28 to 50)
P=0.649
86 (49–140)
–10 (–63 to 18)
P=0.408
83 (38–124)
–7 (–53 to 45)
P=0.866
79 (55–116)
–18 (–38 to 6)
P=0.027
SOL in minutes (first night)
∆ second night vs first night
41 (19–51)
13 (–15 to 16)
P=0.705
17 (6–25)
–1 (–14 to 10)
P=0.938
11 (1–21)
5 (–1 to 19)
P=0.176
27 (15–52)
0 (–15 to 18)
P=0.794
Notes: Significant differences between the second and the first night are marked in bold (P<0.05 Wilcoxon signed-rank test). The results are presented as median results. 
The numbers in parentheses show the IQR.
Abbreviations: AI, arousal index; AWA, awakening; N1/N2, NREM sleep stage 1/2; NREM, non-REM; PLMD, periodic limb movement disorder; REM, rapid eye movement; 
RLS, restless legs syndrome; SOL, sleep onset latency; SRBD, sleep-related breathing disorder; SWS, slow wave sleep; TB, time spent in bed; WASO, wake after sleep onset.
correlations between age and PSG parameters in different 
subgroups by scatter plots.
Discussion
Although the observed FNE in H-PSG was smaller as 
described using I-PSG and has not been accompanied by 
a reduced SE, even in an outpatient setting a significant 
FNE in H-PSG exists. In particular, MS patients suffering 
from SRBD and PLMD/RLS showed a clear FNE – prob-
ably caused by the discomfort provoked by electrodes and 
cables. In contrast, in MS patients suffering from insom-
nia, no significant RFNE could be found, similar to other 
studies which did not show an RFNE in insomniacs in an 
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outpatient setting.12–14 The RFNE is usually caused by the 
unusual environment and the feeling to be under observa-
tion. In this study, the patients were not filmed; moreover, 
they slept at home. This could be the reason why especially 
in insomniacs no significant RFNE was found.
Newell et al26 compared two consecutive I-PSGs, and 
the patients were divided into four subgroups: insomnia, 
SRBD, PLMD/parasomnia, and healthy controls (HCs). 
When comparing both nights of all four groups separately, 
the changes between the two I-PSGs were most pronounced 
in the insomnia group. In particular, in this study, SRBD 
patients showed in the first night no reduced WASO time, 
no reduced REM, and no increased sleep latencies (RSL or 
SOL) – similar to the SRBD patients in our study. Against 
this background, we can summarize that the FNE in SRBD 
patients found in our study seems to be very similar to the 
FNE in the sleep laboratory observed by Newell et al and 
that this FNE is most likely caused by the cables itself and 
not by the unfamiliar environment.
On the other hand, MS patients suffering from insomnia 
showed, in the familiar environment (in contrast to the study by 
Newell et al), no significant changes between the two consecu-
tive nights. It could therefore be concluded that the RFNE in 
Table 3 Spearman’s rank correlations of the FNE with age within each subgroup
Spearman’s rank correlation with age (years) Insomnia   
(n=17)
No sleep  
disorder (n=17)
SRBD  
(n=7)
PLMD/RLS  
(n=22)
∆ AI (per hour of sleep) Correlation coefficient –0.401 –0.517 0.090 –0.276
P-value 0.111 0.034 0.848 0.214
∆ WASO (minutes) Correlation coefficient 0.418 –0.004 0.108 0.156
P-value 0.095 0.987 0.818 0.488
∆ Number of sleep stage 
changes
Correlation coefficient 0.169 –0.102 –0.324 –0.117
P-value 0.518 0.696 0.478 0.605
∆ Number of AWAs Correlation coefficient 0.085 –0.023 –0.477 0.091
P-value 0.746 0.929 0.279 0.687
∆ SE (% of TSiB) Correlation coefficient –0.370 –0.237 –0.180 0.046
P-value 0.144 0.360 0.699 0.840
∆ NREM sleep 1+2 (% of 
TSiB)
Correlation coefficient –0.448 0.121 0.577 –0.302
P-value 0.072 0.644 0.175 0.171
∆ Slow wave sleep (N3)  
(% of TSiB)
Correlation coefficient 0.049 –0.228 –0.144 0.053
P-value 0.851 0.379 0.758 0.813
∆ NREM sleep (% of 
TSiB)
Correlation coefficient –0.080 0.002 0.468 –0.191
P-value 0.760 0.993 0.289 0.394
∆ REM latency (minutes) Correlation coefficient –0.620 –0.116 –0.360 0.088
P-value 0.014 0.670 0.427 0.697
∆ SOL (minutes) Correlation coefficient 0.286 0.274 –0.450 –0.424
P-value 0.266 0.286 0.310 0.049
∆ REM sleep (% of TSiB) Correlation coefficient –0.068 –0.324 –0.144 0.451
P-value 0.796 0.205 0.758 0.035
Notes: Changes in sleep parameters between night 1 and night 2 were analyzed. Significant differences between the second and the first night are marked in bold (P<0.05 
Wilcoxon signed-rank test).
Abbreviations: AI, arousal index; AWA, awakening; FNE, first night effect; N3, NREM sleep stage 3; NREM, non-REM; PLMD, periodic limb movement disorder; REM, 
rapid eye movement; RLS, restless legs syndrome; SE, sleep efficacy; SOL, sleep onset latency; SRBD, sleep-related breathing disorder; TSiB, time spent in bed; WASO, wake 
after sleep onset.
insomnia patients found in previous studies (using I-PSG in the 
sleep laboratory) has been probably caused by the unfamiliar 
environment. This is clinically important: the point in ques-
tion is, how many H-PSGs should be performed at home in 
insomnia and SRBD and RLS/PLMD patients. The fact that 
insomnia patients showed no RFNE in our study argues for 
only one H-PSG in these patients. Due to the fact that a typi-
cal FNE was found in SRBD patients at home, two H-PSGs 
should be performed for a correct diagnosis. On the other hand, 
it must be respected that in SRBD patients PSGs (H-PSG or 
I-PSG) are usually performed for a correct diagnosis of SRBD, 
and it can be expected that in the clinical routine two H-PSGs 
will not be routinely required for a correct SRBD diagnosis.
Moreover, in MS patients without sleep disorders, only 
an increased number of AWAs were found in the first night, 
what goes along with studies which failed to demonstrate 
a significant FNE in an outpatient setting in HCs. In MS 
patients suffering from PLMD/RLS, NREM sleep was 
reduced in the first night and sleep latencies and WASO time 
were increased. Therefore, even if the SE and TST showed no 
significant changes between the two nights, we found smaller 
changes which corresponded – albeit to a lesser extent – to 
those observed in I-PSG.
 
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
Nature and Science of Sleep 2018:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
342
Veauthier et al
Figure 1 In some sleep parameters, age-related changes between the two nights were found.
Notes: In MS patients suffering from insomnia, younger age was correlated with an increased REM latency in the first night (A). In MS patients suffering from PLMD or RLS, 
older patients spent less time in REM sleep in the first night (B), whereas younger patients needed more time to fall asleep in the first night (C). Older MS patients without 
any sleep disorder showed a larger decrease in arousal between the first and second night, indicating possible indication for a slight FNE in older patients (D). In summary, 
the age-related changes were relatively small, and older and younger patients were similarly affected although in various parameters: Amongst MS patients suffering from 
insomnia or PLMD/RLS, the younger the patient the smaller the REM latency and sleep onset latency. In MS patients without sleep disorders, the older the patients the higher 
the number of arousal in the first night. But, in general, it cannot be said that older or younger patients showed a more pronounced FNE.
Abbreviations: AI, arousal index; FNE, first night effect; MS, multiple sclerosis; PLMD, periodic limb movement disorder; REM, rapid eye movement; RLS, restless legs 
syndrome; SOL, sleep onset latency; SRBD, sleep-related breathing disorder; TSiB, time spent in bed.
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First night effect of home-based polysomnography
In summary, MS patients suffering from sleep distur-
bances who were suffering from SRBD and PLMD/RLS 
showed a clear FNE in the H-PSG, which was in PLMD/
RLS patients less pronounced than in the sleep laboratory 
but should be taken into account in all studies investigating 
sleep in these patients. Due to the fact that only MS patients 
were investigated in this study, these findings cannot be 
generalized to the general population. However, a recently 
published study shows that insomnia comorbid to MS is 
associated with the same classical psychological factors 
as insomnia in the general population.27 That means that 
insomnia in MS patients is not different from insomnia in 
the general population. In our study, MS patients suffering 
from insomnia showed in the first night a nonsignificantly 
increased sleep efficiency and a nonsignificantly decreased 
sleep latency. These findings, even if they are not significant 
and less pronounced than in the sleep laboratory, correspond 
to what is described about RFNE in insomnia in the sleep 
laboratory (it points in the same direction). Therefore, there 
are no arguments that our findings are specific for the MS 
population. The small nonsignificant improvement in sleep 
in MS patients suffering from insomnia in the first night and 
the observed significant FNE in MS patients suffering from 
SRBD and RLS/PLMD are in line with the RFNE/FNE in the 
sleep laboratory described in the literature, and it cannot be 
expected that these results are caused by the MS itself even if 
the MS can be theoretically a substantial confounder. Taken 
together, to investigate the FNE and RFNE in an outpatient 
setting, larger prospective studies using the new AASM cri-
teria in patients suffering only from sleep disorders without 
MS and other comorbid diseases should be performed.
Methodical limitations
This is a retrospective analysis of a cross-sectional study 
published in Multiple Sclerosis Journal in 2011. The original 
study began in 2007, in the year in which the new scoring 
criteria by the AASM were published. The used PSG systems 
(two of them provided by Weinmann Medical Technology) 
measured sleep by C3-A2 and C4-C1 electrodes and did not 
have frontal and occipital electrodes. Therefore, the PSG had 
to be evaluated subsequently by the older R&K criteria. It 
would of course be preferable to perform larger prospective 
studies with the new AASM criteria. Nevertheless, against 
the background of the increasing importance of H-PSG and 
the very small number of studies investigating the FNE and 
RFNE in an outpatient setting, this retrospective analysis is 
clinically important, and the use of the R&K criteria is not 
a major methodological problem. Another methodological 
limitation consists of the fact that only MS patients have 
been investigated, and the results cannot be generalized on 
the general population.
Conclusion
In patients suffering from SRBD and PLMD/RLS, there was 
a clear FNE, in PLMD/RLS albeit to a lesser extent compared 
to the FNE observed in the sleep laboratory. Therefore, in 
studies using H-PSG in an outpatient setting, two consecu-
tive H-PSGs should be performed for a precise diagnosis. 
As, on the other hand, the FNE seems not sufficiently pro-
nounced to misdiagnose SRBD or RLS/PLMD, in the clinical 
routine it might be considered to perform only one H-PSG 
to discover SRBD or RLS/PLMD. In PLMD/RLS patients, 
age-related changes were found in various parameters – as 
well in younger and in older MS patients.
In MS patients suffering from insomnia, no RFNE was 
found – probably due to the absence of the observation of the 
patient. In insomnia patients, one H-PSG seems to be suf-
ficient for a correct diagnosis. MS patients without comorbid 
sleep disorders did not show an FNE (apart from an increased 
number of AWAs in the first night).
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